Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar 1;1(1):48-57.
doi: 10.1007/s40521-013-0004-7.

Oral and sublingual immunotherapy

Edwin H Kim  1 , Wesley Burks  2
Affiliations

Oral and sublingual immunotherapy

Edwin H Kim et al. Curr Treat Options Allergy. .

Abstract

Allergic diseases have continued to increase throughout the developed world. Subcutaneous immunotherapy has been a mainstay of treatment for allergic rhinitis and asthma, however, some patients are precluded from treatment. On the other hand, in the case of food allergy, treatments simply do not exist. Oral and sublingual immunotherapy, with its superior safety and ease of administration, offers an alternative for patients with allergic rhinitis and asthma and has also been promising as a potential treatment for food allergy. The review summarizes significant advances from the past year including further data on the effectiveness of existing treatments, preliminary data on novel treatments, and further understanding of the mechanisms of these new therapies.

Keywords: allergic rhinitis; allergic rhinoconjunctivitis; asthma; food allergy; oral immunotherapy; sublingual immunotherapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

Edwin H Kim is on the medical advisory board for Triangle E Technologies and Kyruus. Wesley Burks is the President of AAAAI; is currently a consultant to GLG Research, Nutricia North America, and Regeneron Pharmaceuticals; received honoraria from Levine's Children's Hospital; received payment for development of educational presentations from Mylan Specialty; and has stock/stock options with Mastcell Pharmaceuticals.

References

    1. Schiller JS, Lucas JW, Ward BW, Peregoy JA. Summary health statistics for U.S. adults: National Health Interview Survey, 2010. Vital and health statistics Series 10, Data from the National Health Survey. 2012;(252):1–207. - PubMed
    1. Bloom B, Cohen RA, Freeman G. Summary health statistics for U.S. children: National Health Interview Survey, 2011. Vital and health statistics Series 10, Data from the National Health Survey. 2012;(254):1–80. - PubMed
    1. Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol. 1998;102(4 Pt 1):558–562. - PubMed
    1. Di Bona D, Plaia A, Leto-Barone MS, et al. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison. J Allergy Clin Immunol. 2012;130(5):1097–1107. e1092. - PubMed
    1. Cox LS, Larenas Linnemann D, Nolte H, et al. Sublingual immunotherapy: a comprehensive review. J Allergy Clin Immunol. 2006;117(5):1021–1035. - PubMed

LinkOut - more resources